Eli Lilly and Co (NYSE:LLY)
| 324.56 Delayed Data As of Jun 30 |  +1.56 / +0.48%Today’s Change | 220.20 Today|||52-Week Range 330.85 | +17.50% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 323.00 |
| Today’s open | 319.80 |
| Day’s range | 319.80 - 327.10 |
| Volume | 2,732,891 |
| Average volume (3 months) | 3,068,652 |
| Market cap | $309.4B |
Data as of 4:02pm ET, 06/30/2022
Growth & Valuation
| Earnings growth (last year) | -9.81% |
| Earnings growth (this year) | +2.55% |
| Earnings growth (next 5 years) | +16.27% |
| Revenue growth (last year) | +15.40% |
| P/E ratio | 48.2 |
| Price/Sales | 8.89 |
| Price/Book | 34.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +1.56 | +3.06% |
| ABBVAbbVie | -0.73 | -0.47% |
| MRKMerck | -1.16 | -1.25% |
| AZNAstraZeneca | -0.94 | -1.40% |
Data as of 5:48pm ET, 06/30/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | $1.73 |
| Annual revenue (last year) | $28.3B |
| Annual profit (last year) | $5.6B |
| Net profit margin | 19.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
